Literature DB >> 7625621

Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants.

D Giugliano1, R Marfella, G Verrazzo, R Acampora, C Donzella, A Quatraro, L Coppola, F D'Onofrio.   

Abstract

OBJECTIVE: To evaluate 1) the hemorrheologic and hemodynamic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and 2) the influence of antioxidants on these effects.
DESIGN: Case-control study.
SETTING: University hospital clinic. PATIENTS: 40 patients with diabetes and no evidence of cardiovascular complications and 40 controls matched for demographic variables and body habitus.
INTERVENTIONS: Sublingual glyceryl trinitrate (0.3 mg) and transdermal glyceryl trinitrate patches (10 mg/d). Vitamin E, 300 mg/d orally for 7 days, and glutathione, 600 mg intravenously or intramuscularly, were given to test the effects of antioxidant supplementation. MEASUREMENTS: Systolic, diastolic, and mean arterial pressure and heart rate; left ventricular ejection fraction; platelet aggregation, blood viscosity, and blood filterability in vitro and ex vivo.
RESULTS: Compared with controls, patients with diabetes had increased platelet aggregation to adenosine diphosphate (P < 0.005), increased blood viscosity (P < 0.001), and decreased blood filterability (P = 0.041) at baseline; blood pressure, heart rate, and ejection fraction were similar in the two groups. In controls, both sublingual glyceryl trinitrate and transdermal glyceryl trinitrate patches significantly reduced platelet aggregation (-38%; 95% CI, -49% to -27%) and blood viscosity (-8%; CI, -11% to -5%) and increased blood filterability (10%; CI, 7.0% to 13.1%). Slight but significant decreases in blood pressure and ejection fraction and an increase in heart rate were also seen in controls after administration of glyceryl trinitrate (both preparations). In patients with diabetes, glyceryl trinitrate paradoxically increased platelet aggregation (24%; CI, 15% to 33%) and blood viscosity (6%; CI, 2.9% to 8.8%) and decreased blood filterability (-7%; CI, -9.5% to -4.4%); hemodynamic values did not change significantly. In both groups, rheologic responses to glyceryl trinitrate (end concentration, 100 and 200 ng/mL) in vitro were similar to those seen in ex vivo studies. Vitamin E and glutathione normalized rheologic responses to glyceryl trinitrate in patients with diabetes.
CONCLUSIONS: Organic nitrates have beneficial effects on blood rheology in controls but not in patients with diabetes, in whom a paradoxical deterioration is seen. Antioxidant supplementation can normalize primary tolerance to the rheologic effects of nitrates in diabetes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625621     DOI: 10.7326/0003-4819-123-5-199509010-00003

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  The vascular effects of L-Arginine in humans. The role of endogenous insulin.

Authors:  D Giugliano; R Marfella; G Verrazzo; R Acampora; L Coppola; D Cozzolino; F D'Onofrio
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

2.  Influence of nitrovasodilators and endothelin-1 on rheology of human blood in vitro.

Authors:  R Walter; M Mark; R Gaudenz; L G Harris; W H Reinhart
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

3.  Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver.

Authors:  Rakhee S Gupte; Beverly C Floyd; Mark Kozicky; Shimran George; Zoltan I Ungvari; Vanessa Neito; Michael S Wolin; Sachin A Gupte
Journal:  Free Radic Biol Med       Date:  2009-02-20       Impact factor: 7.376

4.  Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats.

Authors:  Ellen Q Wang; Ho-Leung Fung
Journal:  AAPS PharmSci       Date:  2002

5.  Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH.

Authors:  Sabrina Serpillon; Beverly C Floyd; Rakhee S Gupte; Shimran George; Mark Kozicky; Venessa Neito; Fabio Recchia; William Stanley; Michael S Wolin; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

Review 6.  Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

Authors:  Matthias Oelze; Swenja Schuhmacher; Andreas Daiber
Journal:  Exp Diabetes Res       Date:  2010-12-27

7.  Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats.

Authors:  K C Choi; S C Lee; S W Kim; N H Kim; J U Lee; Y J Kang
Journal:  Korean J Intern Med       Date:  1999-01       Impact factor: 2.884

8.  Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione.

Authors:  Wayne Kaesemeyer; Tatsiana Suvorava
Journal:  Am J Cardiovasc Drugs       Date:  2021-03-22       Impact factor: 3.571

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.